Severe Hypophosphatemia in Adolescent Cannabis User  

作　　者：Chantel Johnson Michael J. Thomas Michael Halata Dmitry Samsonov Chantel Johnson;Michael J. Thomas;Michael Halata;Dmitry Samsonov(Department of Pediatrics, Maria Fareri Children’s Hospital/Westchester Medical Center Health Network, Valhalla, NY, USA;Department of Pediatrics, New York Medical College, Valhalla, NY, USA;Department of Pediatric Gastroenterology & Nutrition, Maria Fareri Children’s Hospital/Westchester Medical Center Health Network, Valhalla, NY, USA;Boston Children’s Health Physicians, Hawthorne, NY, USA;Department of Pediatric Nephrology, Maria Fareri Children’s Hospital/Westchester Medical Center Health Network, Valhalla, NY, USA)

机构地区：[1]Department of Pediatrics, Maria Fareri Children’s Hospital/Westchester Medical Center Health Network, Valhalla, NY, USA [2]Department of Pediatrics, New York Medical College, Valhalla, NY, USA [3]Department of Pediatric Gastroenterology & Nutrition, Maria Fareri Children’s Hospital/Westchester Medical Center Health Network, Valhalla, NY, USA [4]Boston Children’s Health Physicians, Hawthorne, NY, USA [5]Department of Pediatric Nephrology, Maria Fareri Children’s Hospital/Westchester Medical Center Health Network, Valhalla, NY, USA

出　　处：《Open Journal of Pediatrics》2023年第4期496-501,共6页儿科学期刊（英文）

摘　　要：Cannabinoid hyperemesis syndrome (CHS) involves cyclical nausea, vomiting, and abdominal pain linked to use of cannabis with resolution of symptoms upon cessation of cannabinoids. Although electrolyte disturbances, fluid imbalances, and nutritional deficiencies are known complications of CHS in the setting of intractable vomiting, severe hypophosphatemia is a rare clinical phenomenon cited primarily in the adult literature. Pediatric cases are scarcer, thus the magnitude associated with our patient case describes an adolescent diagnosed with CHS complicated by recurrent severe hypophosphatemia. As cannabis accessibility and potential for abuse increase with the wave of legalization seen at the state level, clinician awareness is needed for such adverse entities related to cannabinoid toxicity.Cannabinoid hyperemesis syndrome (CHS) involves cyclical nausea, vomiting, and abdominal pain linked to use of cannabis with resolution of symptoms upon cessation of cannabinoids. Although electrolyte disturbances, fluid imbalances, and nutritional deficiencies are known complications of CHS in the setting of intractable vomiting, severe hypophosphatemia is a rare clinical phenomenon cited primarily in the adult literature. Pediatric cases are scarcer, thus the magnitude associated with our patient case describes an adolescent diagnosed with CHS complicated by recurrent severe hypophosphatemia. As cannabis accessibility and potential for abuse increase with the wave of legalization seen at the state level, clinician awareness is needed for such adverse entities related to cannabinoid toxicity.

关 键 词：CANNABINOID TOXICITY HYPEREMESIS 

分 类 号：R73[医药卫生—肿瘤]